Merit will be exhibiting at GEST 2022: Global Embolization Oncology Symposium Technologies. This year’s annual conference features an international audience with in-person training and hands-on workshops in New York, NY. Our theme for this year’s Symposium is The Flow Stops Here, a bold commitment to offering high-quality embolotherapy products and services designed to improve outcomes for physicians and their patients.
PRODUCT SHOWCASE AT BOOTH #801
The most clinically studied spherical embolic, Merit’s Embosphere Microspheres are the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolization of symptomatic uterine fibroids, ABMs, and hypervascular tumors, the elastic material allows for temporary compression of up to 33%,1 yielding targeted results for patients and practitioners.
Specifically designed for embolization of hypervascular tumors and blood vessels to occlude blood flow, Embocube Embolization Gelatin consistently controls hemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.
The SwiftNINJA Steerable Microcatheter is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.
We look forward to seeing you at GEST 2022—where #TheFlowStopsHere!
Questions? Contact our Customer Support Center, and speak to one of our representatives via live chat, phone, or email.
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
- Laurent et al. 1996. “Trisacryl Gelatin Microspheres for Therapeutic Embolization, I: Development and In Vitro Evaluation.” Am J Neuroradial 17:533-540